Primary small cell neuroendocrine carcinoma of the tonsil: a case report and review of the literature

Abstract

Small cell neuroendocrine carcinoma (NEC) that originates in the tonsil is extremely rare and carries a poor prognosis. Only a few cases of this tumor have been reported so far and the standard treatment protocol remains uncertain. Here we describe a 74-year-old woman presented with throat pain for about 2 months. Computed tomography (CT) scan revealed a 3.4×1.8 cm tumor with moderate enhancement in the left tonsil and a 1.3×1.0 cm neck mass in left level II. A biopsy of the tonsillar mass was performed and histologic examination revealed small round to oval tumor cells were arranged in cords or nests, containing hyperchromatic nuclei and scant cytoplasm. Mitotic figures were readily identified. Immunohistochemical staining showed that tumor cells were strongly positive for CD56, focally positive for PCK and negative for LCA. A diagnosis of primary small cell NEC of the left tonsil was obtained. The patient was treated by six cycles of cisplatin combined with etoposide and the masses showed initial complete response. But recurrence in the left neck was found 9 months after initial diagnosis and the patient refused any further treatment. With a review of the literature, the nomenclature, clinicopathological characteristics and treatment modalities of this rare tumor are discussed.

Keywords: Neuroendocrine carcinoma; immunohistochemistry; oropharynx; small cell carcinoma; tonsil.

Figure 1

CT scan shows the contrast-enhancing mass originating from the left tonsil (arrows).

Figure 2

H. E. staining shows small round to oval tumor cells with scant cytoplasm, hyperchromatic nuclei and unobvious nucleoli. Mitoses (arrow) and necrosis are identified (A). Immunohistochemical study shows that tumor cells are strongly positive for CD56 (B), focally positive for PCK (C) and negative for LCA (D). Original magnification × 400.